000 | 01567 a2200469 4500 | ||
---|---|---|---|
005 | 20250516070938.0 | ||
264 | 0 | _c20120423 | |
008 | 201204s 0 0 eng d | ||
022 | _a1932-6203 | ||
024 | 7 |
_a10.1371/journal.pone.0028727 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGilboa-Geffen, Adi | |
245 | 0 | 0 |
_aActivation of the alternative NFκB pathway improves disease symptoms in a model of Sjogren's syndrome. _h[electronic resource] |
260 |
_bPloS one _c2011 |
||
300 |
_ae28727 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBiomarkers _xmetabolism |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammation Mediators _xmetabolism |
650 | 0 | 4 |
_aLeukocytes, Mononuclear _xpathology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
650 | 0 | 4 |
_aSaliva _xmetabolism |
650 | 0 | 4 |
_aSalivary Glands _xmetabolism |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 |
_aSjogren's Syndrome _xmetabolism |
650 | 0 | 4 |
_aToll-Like Receptor 9 _xagonists |
700 | 1 | _aWolf, Yochai | |
700 | 1 | _aHanin, Geula | |
700 | 1 | _aMelamed-Book, Naomi | |
700 | 1 | _aPick, Marjorie | |
700 | 1 | _aBennett, Estelle R | |
700 | 1 | _aGreenberg, David S | |
700 | 1 | _aLester, Susan | |
700 | 1 | _aRischmueller, Maureen | |
700 | 1 | _aSoreq, Hermona | |
773 | 0 |
_tPloS one _gvol. 6 _gno. 12 _gp. e28727 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0028727 _zAvailable from publisher's website |
999 |
_c21396824 _d21396824 |